Growth Metrics

Guardant Health (GH) Common Equity (2017 - 2025)

Historic Common Equity for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$354.5 million.

  • Guardant Health's Common Equity fell 48984.46% to -$354.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$354.5 million, marking a year-over-year decrease of 48984.46%. This contributed to the annual value of -$139.6 million for FY2024, which is 18800.32% down from last year.
  • Per Guardant Health's latest filing, its Common Equity stood at -$354.5 million for Q3 2025, which was down 48984.46% from -$305.5 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Common Equity registered a high of $847.0 million during Q1 2021, and its lowest value of -$354.5 million during Q3 2025.
  • In the last 5 years, Guardant Health's Common Equity had a median value of $158.7 million in 2023 and averaged $192.6 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 25327.38% in 2024, then plummeted by 1883831.37% in 2025.
  • Guardant Health's Common Equity (Quarter) stood at $645.0 million in 2021, then crashed by 90.67% to $60.2 million in 2022, then surged by 163.68% to $158.7 million in 2023, then plummeted by 188.0% to -$139.6 million in 2024, then crashed by 153.84% to -$354.5 million in 2025.
  • Its Common Equity stands at -$354.5 million for Q3 2025, versus -$305.5 million for Q2 2025 and -$250.8 million for Q1 2025.